April 3, 2023 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announced that it has submitted an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) on 31 March 2023 for its second-generation DSR product (

Here's a look at what viewers found most interesting during the month of March

In the blink of an eye yet another month has passed, and here is a look at the Top 10 of what DIcardiology.com viewers found to be most interesting during the month of March.

1. Biological Clock Shock? “Springing Forward” May Have Drawbacks For Heart Health

Dr. Maurice Alston an interventional cardiologist at Tennova Medical Center in Cleveland, Tenn. He is passionate about tackling the challenges related to the number one cause of mortality in the United States. His work in interventional cardiology is focused on minimally invasive procedures and preventative medicine.

March 31, 2023 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the company's Epic Max stented tissue valve to treat people with aortic regurgitation or stenosis.

Endovascular Cardiac Complications - ECC Congress

CTO Live Aid 4th Edition

March 31, 2023 — Scientists of the Department of Animal Biology of the University of Malaga have discovered the cellular mechanism that originates coronary arterio-ventricular fistulae, a congenital anomaly that, in severe cases, may result in death.

March 31, 2023 — In a study among residents of Ventura County, Calif., rates of sudden cardiac arrest rose sharply during the COVID-19 pandemic.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now